Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer Meeting Abstract


Authors: Arbour, K. C.; Ricciuti, B.; Rizvi, H.; Hellmann, M. D.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; Rudin, C. M.; Lito, P.; Awad, M. M.; Riely, G. J.
Abstract Title: Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120605067
DOI: 10.1200/JCO.2021.39.15_suppl.9088
PROVIDER: wos
Notes: Meeting Abstract: 9088 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    291 Yu
  2. Piro Lito
    58 Lito
  3. Marc Ladanyi
    1334 Ladanyi
  4. Gregory J Riely
    605 Riely
  5. Maria Eugenia Arcila
    670 Arcila
  6. Mark Kris
    872 Kris
  7. Matthew David Hellmann
    412 Hellmann
  8. Charles Rudin
    496 Rudin
  9. Kathryn Cecilia Arbour
    89 Arbour
  10. Hira Abbas Rizvi
    123 Rizvi